Prospective evaluation of body surface area as a determinant of paclitaxel pharmacokinetics and pharmacodynamics in women with solid tumors: Cancer and Leukemia Group B Study 9763.

Prospective evaluation of body surface area as a determinant of paclitaxel pharmacokinetics and pharmacodynamics in women with solid tumors: Cancer and Leukemia Group B Study 9763. Clin Cancer Res. 2004 Dec 15; 10(24):8325-31.

View in: PubMed

subject areas

Adult
Aged
Antineoplastic Agents, Phytogenic
Area Under Curve
Body Surface Area
Chromatography, High Pressure Liquid
Dose-Response Relationship, Drug
Female
Follow-Up Studies
Humans
Metabolic Clearance Rate
Middle Aged
Neoplasms
Paclitaxel
Prospective Studies

authors with profiles

Mark J. Ratain